Real-World Analysis Examining Cost of Early Disease Progression among Patients with Epidermal Growth Factor Receptor Mutated Metastatic Non-Small Cell Lung Cancer
07:30am - 03:45pm EST - March 31, 2023
07:30am - 03:45pm EST - March 31, 2023
Author(s):
- Elizabeth Marrett, MPH, Director, Health Economics and Outcomes Research, Daiichi Sankyo Inc
Tags: Outcomes and Health Services Research
| Display Label | Action |
|---|---|
| AC23P32 - Real-World Analysis Examining Cost of Early Disease Progression among Patients with Epidermal Growth Factor Receptor Mutated Metastatic Non-Small Cell Lung Cancer | Download MP3 |
| 032-General Poster Session | Download Handout |